Skip to main content
SpringerLink
Log in
Book cover

Pediatric Hypertension pp 1–21Cite as

Endocrine Hypertension

  • 195 Accesses

Abstract

Hypertension may be caused by abnormal synthesis of, or response to, various hormones. The proportion\ of pediatric hypertension cases resulting from such problems probably represents at most a few percent of cases overall, but a higher fraction of cases of severe hypertension, those occurring in the very young, or cases clustering in families. Most endocrine hypertension involves the adrenal gland and its hormones. The adrenal gland is composed of two endocrine tissues: the medulla (secreting catecholamines) and the cortex (synthesizing cortisol and aldosterone). Pheochromocytoma is mainly a disease of the adrenal medulla, although extramedullary sites may be involved. Many different diseases affecting the adrenal cortex can cause hypertension. These include hypertensive forms of congenital adrenal hyperplasia, primary aldosteronism due to hyperplasia of the zona glomerulosa or to adenomas, and Cushing’s syndrome (excessive glucocorticoid exposure) due to iatrogenic etiologies, to pituitary or adrenal adenomas, or to other tumors secreting excessive ACTH. Hypertension can also be caused by thyrotoxicosis due to Graves’ disease or to the thyrotoxic phase of Hashimoto’s thyroiditis. It is important to accurately diagnose these disorders because the associated hypertension requires, and usually responds well to, specific treatment of the underlying hormonal abnormality.

This is a preview of subscription content, log in via an institution.

References

  • Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metabol 88(12):5593–5602

    Article  CAS  Google Scholar 

  • Assie G, Libe R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W, Barreau O, Lefevre L, Sibony M, Guignat L, Rodriguez S, Perlemoine K, Rene-Corail F, Letourneur F, Trabulsi B, Poussier A, Chabbert-Buffet N, Borson-Chazot F, Groussin L, Bertagna X, Stratakis CA, Ragazzon B, Bertherat J (2013) ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome. N Engl J Med 369(22):2105–2114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Auchus RJ (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. [Review] [77 refs]. Endocrinol Metab Clin North Am 30(1):101–119

    Article  CAS  PubMed  Google Scholar 

  • Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metabol 96(3):717–725

    Article  CAS  Google Scholar 

  • Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21(6):593–646

    Article  Google Scholar 

  • Barker FG, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metabol 88(10):4709–4719

    Article  CAS  Google Scholar 

  • Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE (2004) The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 18(2):279–290

    Article  CAS  PubMed  Google Scholar 

  • Batista DL, Riar J, Keil M, Stratakis CA (2007) Diagnostic tests for children who are referred for the investigation of Cushing’s syndrome. Pediatrics 120(3):e575–e586

    Article  PubMed  Google Scholar 

  • Beuschlein F, Fassnacht M, Assie G, Calebiro D, Stratakis CA, Osswald A, Ronchi CL, Wieland T, Sbiera S, Faucz FR, Schaak K, Schmittfull A, Schwarzmayr T, Barreau O, Vezzosi D, Rizk-Rabin M, Zabel U, Szarek E, Salpea P, Forlino A, Vetro A, Zuffardi O, Kisker C, Diener S, Meitinger T, Lohse MJ, Reincke M, Bertherat J, Strom TM, Allolio B (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med 370(11):1019–1028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brenta G, Danzi S, Klein I (2007) Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab 3(9):632–640

    Article  CAS  PubMed  Google Scholar 

  • Charmandari E, Kino T, Ichijo T, Chrousos GP (2008) Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metabol 93(5):1563–1572

    Article  CAS  Google Scholar 

  • Charmandari E, Kino T, Chrousos GP (2013) Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev 24:67–85. doi:10.1159/000342505. Epub;%2013 Feb 1, 67–85

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39(6):775–783

    Article  PubMed  PubMed Central  Google Scholar 

  • Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Akerstrom G, Wang W, Carling T, Lifton RP (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331(6018):768–772

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cicala MV, Mantero F (2010) Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology 92(Suppl 1):44–49. Epub;%2010 Sep 10, 44–49

    Article  CAS  PubMed  Google Scholar 

  • Clark AJ, Metherell LA (2006) Mechanisms of disease: the adrenocorticotropin receptor and disease. Nat Clin Pract Endocrinol Metab 2(5):282–290

    Article  CAS  PubMed  Google Scholar 

  • Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM (2012) A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med 366(10):914–924

    Article  CAS  PubMed  Google Scholar 

  • Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE (2002) Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143(9):3651–3657

    Article  CAS  PubMed  Google Scholar 

  • Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5:1513–1522

    Article  CAS  PubMed  Google Scholar 

  • Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A 90:4552–4556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dannenberg H, van Nederveen FH, Abbou M, Verhofstad AA, Komminoth P, de Krijger RR, Dinjens WN (2005) Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD. J Clin Oncol 23(9):1894–1901

    Article  CAS  PubMed  Google Scholar 

  • Derlin T, Busch JD, Wisotzki C, Schoennagel BP, Bannas P, Papp L, Klutmann S, Habermann CR (2013) Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Clin Nucl Med 38(1):e1–6

    Google Scholar 

  • Donckier JE, Michel L (2010) Phaeochromocytoma: state-of-the-art. Acta Chir Belg 110(2):140–148

    Article  CAS  PubMed  Google Scholar 

  • Dumitrescu AM, Refetoff S (2007) Novel biological and clinical aspects of thyroid hormone metabolism. Endocr Dev 10:127–139

    CAS  PubMed  Google Scholar 

  • Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011) Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metabol 96(2):375–384

    Article  CAS  Google Scholar 

  • Eisenhofer G, Lattke P, Herberg M, Siegert G, Qin N, Darr R, Hoyer J, Villringer A, Prejbisz A, Januszewicz A, Remaley A, Martucci V, Pacak K, Ross HA, Sweep FC, Lenders JW (2013) Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann Clin Biochem 50(Pt 1):62–69

    Google Scholar 

  • Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Mussig K, Muresan M, Schaffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plockinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP (2009) Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 15(20):6378–6385

    Article  CAS  PubMed  Google Scholar 

  • Fishbein L, Nathanson KL (2012) Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet 205(1–2):1–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Funder J (2001) Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol 28(12):1002–1006

    Article  CAS  PubMed  Google Scholar 

  • Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol 93(9):3266–3281

    Article  CAS  Google Scholar 

  • Gershengorn MC, Neumann S (2012) Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 97:4287–4292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112(8):417–428

    Article  CAS  Google Scholar 

  • Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libe R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA (2006) A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38(7):794–800

    Article  CAS  PubMed  Google Scholar 

  • Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libe R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA (2008) A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16(10):1245–1253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ilias I, Divgi C, Pacak K (2011) Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer. Semin Nucl Med 41(5):364–368

    Article  PubMed  PubMed Central  Google Scholar 

  • Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26(1):89–92

    Article  CAS  PubMed  Google Scholar 

  • Kleinau G, Krause G (2009) Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 30(2):133–151

    Article  CAS  PubMed  Google Scholar 

  • Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing’s syndrome. Lancet 386(9996):913–927

    Article  CAS  PubMed  Google Scholar 

  • Lee JA, Grumbach MM, Clark OH (2007) The optimal treatment for pediatric Graves’ disease is surgery. J Clin Endocrinol Metabol 92(3):801–803

    Article  CAS  Google Scholar 

  • Li JS, Flynn JT, Portman R, Davis I, Ogawa M, Shi H, Pressler ML (2010) The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study. J Pediatr 157(2):282–287

    Article  CAS  PubMed  Google Scholar 

  • Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265

    Article  CAS  PubMed  Google Scholar 

  • Lodish M, Stratakis CA (2016) A genetic and molecular update on adrenocortical causes of Cushing’s syndrome. Nat Rev Endocrinol 12(5):255–262

    Article  CAS  PubMed  Google Scholar 

  • Lodish M, Dunn SV, Sinaii N, Keil MF, Stratakis CA (2012) Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J Clin Endocrinol Metabol 97(5):1483–1491

    Article  CAS  Google Scholar 

  • Luiz HV, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T, Wesley R, Adams K, Fojo T, Pacak K (2016) Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study. Clin Endocrinol (Oxf) 85(1):62–69

    Article  Google Scholar 

  • Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56(3):391–396

    Article  CAS  PubMed  Google Scholar 

  • Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32(1):81–151

    Article  CAS  PubMed  Google Scholar 

  • Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10:394–399

    Article  CAS  PubMed  Google Scholar 

  • Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A (2011) Guidelines for the diagnosis and treatment of primary aldosteronism – the Japan Endocrine Society 2009. Endocr J 58(9):711–721

    Article  CAS  PubMed  Google Scholar 

  • Nogueira EF, Rainey WE (2010) Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 151(3):1060–1070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3(2):92–102

    Article  PubMed  Google Scholar 

  • Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC (1992) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 89:8327–8331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rivkees SA, Dinauer C (2007) An optimal treatment for pediatric Graves’ disease is radioiodine. J Clin Endocrinol Metabol 92(3):797–800

    Article  CAS  Google Scholar 

  • Rivkees SA, Mattison DR (2009) Ending propylthiouracil-induced liver failure in children. N Engl J Med 360(15):1574–1575

    Article  CAS  PubMed  Google Scholar 

  • Santos IN, Spadari-Bratfisch RC (2006) Stress and cardiac beta adrenoceptors. Stress 9(2):69–84

    Article  CAS  PubMed  Google Scholar 

  • Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A 109(7):2533–2538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schovanek J, Martucci V, Wesley R, Fojo T, Del RJ, Huynh T, Adams K, Kebebew E, Frysak Z, Stratakis CA, Pacak K (2014) The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study. BMC Cancer 14:523. doi:10.1186/1471-2407-14-523, 523-14

    Article  PubMed  PubMed Central  Google Scholar 

  • Silva JE, Bianco SD (2008) Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 18(2):157–165

    Article  CAS  PubMed  Google Scholar 

  • Soundararajan R, Pearce D, Hughey RP, Kleyman TR (2010) Role of epithelial sodium channels and their regulators in hypertension. J Biol Chem 285(40):30363–30369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steichen O, Zinzindohoue F, Plouin PF, Amar L (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 44(3):221–227

    Article  CAS  PubMed  Google Scholar 

  • Stocco DM (2001) StAR protein and the regulation of steroid hormone biosynthesis. [Review] [162 refs]. Annu Rev Physiol 63:193–213

    Article  CAS  PubMed  Google Scholar 

  • Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD (2012) Factors affecting the aldosterone/renin ratio. Horm Metab Res 44(3):170–176

    Article  CAS  PubMed  Google Scholar 

  • Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, Pieber TR (2010) Aldosterone and arterial hypertension. Nat Rev Endocrinol 6(2):83–93

    Article  CAS  PubMed  Google Scholar 

  • Tomlinson JW, Stewart PM (2005) Mechanisms of disease: selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome. Nat Clin Pract Endocrinol Metab 1(2):92–99. Available from: PM:16929377

    Article  CAS  PubMed  Google Scholar 

  • Turkova H, Prodanov T, Maly M, Martucci V, Adams K, Widimsky J Jr, Chen CC, Ling A, Kebebew E, Stratakis CA, Fojo T, Pacak K (2016) Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma/paraganglioma: an National Institutes Of Health study. Endocr Pract 22(3):302–314

    Article  PubMed  Google Scholar 

  • Vaidya A, Hamrahian AH, Auchus RJ (2015) Genetics of primary aldosteronism. Endocr Pract 21(4):400–405

    Article  PubMed  PubMed Central  Google Scholar 

  • Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C (2010) A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metabol 95(5):2023–2037

    Article  CAS  Google Scholar 

  • Weingarten TN, Cata JP, O’Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76(2):508–511

    Article  PubMed  Google Scholar 

  • Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G (2002) Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metabol 87(5):1955–1960

    Article  CAS  Google Scholar 

  • White PC (2001) Steroid 11 beta-hydroxylase deficiency and related disorders. [Review] [60 refs]. Endocrinol Metab Clin North Am 30(1):61–79

    Article  CAS  PubMed  Google Scholar 

  • White PC, Mune T, Agarwal AK (1997) 11b-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135–156

    CAS  PubMed  Google Scholar 

  • Wilson C (2012) Pituitary function: Cushing’s disease – long-term outcome after transsphenoidal surgery. Nat Rev Endocrinol 8(4):194

    Article  PubMed  Google Scholar 

  • Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2(1):1–12

    Article  PubMed  Google Scholar 

  • Yang M, Soga T, Pollard PJ (2013) Oncometabolites: linking altered metabolism with cancer. J Clin Investig 123(9):3652–3658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Schina M, Cianci R, Giustini S, Sciomer S, Anastasi E, Calvieri S, De TG, Letizia C (2011) Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res 303(5):317–325

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology, Department of Pediatrics, UT Southwestern Medical Center and Children’s Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9063, USA

    Perrin C. White

Authors
  1. Perrin C. White
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Perrin C. White .

Editor information

Editors and Affiliations

  1. Division of Nephrology, Seattle Children's Hospital, Seattle, Washington, USA

    Joseph Flynn

  2. Massachusetts General Hospital, Boston, Massachusetts, USA

    Julie R. Ingelfinger

  3. Arkansas Children's Hospital, University of Arkansas Medical Science, Little Rock, Arkansas, USA

    Karen Redwine

Section Editor information

  1. Division of Nephrology, Seattle Children’s Hospital, 4800 Sand Point Way NE, 98105, Seattle, WA, USA

    Joseph T. Flynn MD, MS

  2. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA

    Joseph T. Flynn MD, MS

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing AG

About this entry

Cite this entry

White, P.C. (2016). Endocrine Hypertension. In: Flynn, J., Ingelfinger, J., Redwine, K. (eds) Pediatric Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-31420-4_25-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31420-4_25-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-3-319-31420-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Endocrine Hypertension
    Published:
    01 May 2022

    DOI: https://doi.org/10.1007/978-3-319-31420-4_25-2

  2. Original

    Endocrine Hypertension
    Published:
    21 December 2016

    DOI: https://doi.org/10.1007/978-3-319-31420-4_25-1

Search

Navigation